Ticker HubNasdaq

ASBP

Aspire-Lakewood Holdings, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

Latest price

$8.91+5.57%

As of Oct 28, 2026, 11:56 AM EDT · Market data by Massive

Market cap

$11.4M

Volume

12K

Previous close

$8.44

Day range

$8.54 – $8.93

Listed

Feb 20, 2025

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $8.70Latest interval $8.91

Newsroom

Latest ASBP coverage

CompanyDeep DiveMar 25, 2025

ASBP: Unlocking Multi-Billion Dollar Markets with Enhanced Drug Delivery

Enter Aspire Biopharma, Inc. (NASDAQ: ASBP), a pioneering company enhancing existing drugs with their patent-pending, soluble sublingual technology. By delivering therapeutic levels of medication rapidly and directly into the bloodstream, Aspire is poised to revolutionize how drugs and supplements are delivered and absorbed.

ASBP

Company overview

Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain-agnostic product portfolio that includes mechatronic actuators, human-machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates around 11 manufacturing facilities globally and serves as a tier-one automotive supplier to OEMs and other industrial firms.

Industry: PHARMACEUTICAL PREPARATIONS
Headquarters: ESTERO, FL
CIK: 0001847345

Company website View advanced chart

SEC filings

8-K/A

8-K

SCHEDULE 13G/A

SCHEDULE 13G/A filing

10-Q

SCHEDULE 13G

SCHEDULE 13G filing

Browse EDGAR

Profile at a glance

Feb 20, 2025

Listed

—

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.